Altair International Corp. (ATAO) financial statements (2020 and earlier)
Company profile
| Business Address |
2360 CORPORATE CIRCLE STE 400 HENDERSON, NV 89074-7722 |
| State of Incorp. | NV |
| Fiscal Year End | March 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 0 | 8 | 5 | 0 | 8 | ||
| Cash and cash equivalents | 0 | 8 | 5 | 0 | 8 | ||
| Total current assets: | 0 | 8 | 5 | 0 | 8 | ||
| Noncurrent Assets | |||||||
| Intangible assets, net (including goodwill) | 200 | 200 | ✕ | ||||
| Intangible assets, net (excluding goodwill) | 200 | 200 | |||||
| Other undisclosed noncurrent assets | 360 | 240 | |||||
| Total noncurrent assets: | 560 | 440 | |||||
| TOTAL ASSETS: | 0 | 8 | 565 | 440 | 8 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 19 | 34 | 21 | 25 | |||
| Accounts payable | 18 | 22 | 0 | 15 | |||
| Interest and dividends payable | 1 | 13 | 21 | 10 | |||
| Debt | 41 | 353 | |||||
| Derivative instruments and hedges, liabilities | 308 | 100 | 100 | ||||
| Due to related parties | 45 | 51 | 244 | ||||
| Other undisclosed current liabilities | 14 | 255 | 100 | 28 | |||
| Total current liabilities: | 78 | 649 | 506 | 506 | |||
| Noncurrent Liabilities | |||||||
| Liabilities, other than long-term debt | 8 | ||||||
| Accounts payable and accrued liabilities | 2 | ||||||
| Due to related parties | 6 | ||||||
| Total noncurrent liabilities: | 8 | ||||||
| Total liabilities: | 78 | 649 | 506 | 506 | 8 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | (78) | (641) | 59 | (66) | (1) | ||
| Common stock | 48 | 32 | 5 | 4 | 4 | ||
| Common stock, share subscribed but unissued, subscriptions receivable | (9) | ||||||
| Common stock, value, subscriptions | 268 | 30 | ✕ | ||||
| Additional paid in capital | 432 | 290 | 297 | 33 | 23 | ||
| Accumulated deficit | (826) | (993) | (243) | (103) | (29) | ||
| Other undisclosed stockholders' equity attributable to parent | 9 | ||||||
| Total stockholders' equity: | (78) | (641) | 59 | (66) | (1) | ||
| TOTAL LIABILITIES AND EQUITY: | 0 | 8 | 565 | 440 | 8 | ||
Income statement (P&L) ($ in thousands)
| 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | ||
|---|---|---|---|---|---|---|
| Gross profit: | (200) | |||||
| Operating expenses | (4) | (640) | (29) | (27) | (28) | |
| Operating income (loss): | (4) | (640) | (229) | 173 | (28) | |
| Nonoperating income (Investment Income, Nonoperating) | 245 | 42 | ||||
| Interest and debt expense | (74) | (138) | (111) | (38) | ||
| Net income (loss): | 167 | (737) | (340) | 135 | (28) | |
| Other undisclosed net income (loss) attributable to parent | 200 | (209) | ||||
| Net income (loss) available to common stockholders, diluted: | 167 | (737) | (140) | (74) | (28) | |
Comprehensive Income ($ in thousands)
| 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | 167 | (737) | (340) | 135 | (28) | |
| Comprehensive income (loss), net of tax, attributable to parent: | 167 | (737) | (340) | 135 | (28) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.